More News

30 Jan 2007 Par Pharmaceutical Receives Approval Of Generic Inderal-LA(R)
30 Jan 2007 Aurobindo bags one more cephalosporin from USFDA
30 Jan 2007 OccuLogix's RHEO-AMD Trial Protocol Cleared by the FDA
26 Jan 2007 Biocryst Initiates Phase II Influenza Clinical Trial To Evaluate Peramivir
26 Jan 2007 Altea Therapeutics Announces Positive Clinical Results for its Basal Insulin Transdermal Patch
26 Jan 2007 BioMimetic Therapeutics Reports Positive Clinical Results Using GEM OS®1 to Treat Distal Radius Fractures
26 Jan 2007 BioMimetic Therapeutics Reports Positive Clinical Results Using GEM OS®1 to Treat Distal Radius Fractures
25 Jan 2007 Kirin and Astellas Enter Into a Licensing Agreement on an Immunosuppressive Fully Human Monoclonal Antibody
25 Jan 2007 Scil Technology Completes Patient Enrollment in European Phase II Sinus Lift Study
25 Jan 2007 Scil Technology Completes Patient Enrollment in European Phase II Sinus Lift Study
25 Jan 2007 MediVas Announces Signing of Collaboration Agreement with Pfizer
25 Jan 2007 MediVas Announces Signing of Collaboration Agreement with Pfizer
25 Jan 2007 Foamix Signs R&D Collaboration And License Agreement With Dr. Reddy's Laboratories, Inc's For The Development And Commercialization Of Psoriasis Foam
24 Jan 2007 Medarex and Compugen Announce Therapeutic Antibody Co-Development Agreement
24 Jan 2007 Barr Pharmaceuticals, Inc.'s Subsidiary Pliva D.D. Receives Approval For Generic ZITHROMAX(R) IV, 500 mg Vial
23 Jan 2007 Halozyme Therapeutics Releases Results of Enhanze Technology Clinical Trial to Improve the Subcutaneous Absorption of a Large Protein Molecule Therapeutic
23 Jan 2007 Innocoll Receives FDA Approval to Commence a Phase 2 Clinical Trial for the Topical Treatment of Infected Diabetic Foot Ulcers With its CollaRx(R) GENTAMICIN
23 Jan 2007 Innocoll Receives FDA Approval to Commence a Phase 2 Clinical Trial for the Topical Treatment of Infected Diabetic Foot Ulcers With its CollaRx(R) GENTAMICIN
23 Jan 2007 Wockhardt signs in-licensing pact with Crawford Healthcare of UK, Launches Vitix for vitiligo skin disorder
23 Jan 2007 Shire licenses the North American rights for SPD754 (apricitabine) to Avexa Ltd
23 Jan 2007 Hikma expands into the oncology market
20 Jan 2007 Penwest Begins Next Study in Development of Nalbuphine ER
20 Jan 2007 Bayer Schering Pharma to develop new imaging compounds for detection of Neurodegenerative Diseases
19 Jan 2007 Alexza Completes Enrollment in AZ-004 Phase IIa Clinical Trial in Schizophrenic Patients with Acute Agitation
19 Jan 2007 Adherex Buys Out Eniluracil Development Options From GlaxoSmithKline

La Merie Biologics

FREE Weekly News Bulletin

Sign Up

2019 Sales ofAntibodies & Proteins

New Product Alert

For La Merie Publishing

Sign Up

Top